The 2026 Special Issue on Radiopharmaceuticals: from Molecular Design to Clinical Translation
Nuclear Medicine and Molecular Imaging · 2026-06 · 60 (3) · 155-156
DOI: 10.1007/s13139-026-01019-2 ↗Kurz gefasst
Editorial in der Zeitschrift Nuclear Medicine and Molecular Imaging, online erschienen am 25.04.2026. Verfasst von Yun-Sang Lee. Beteiligte Einrichtung: Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080 Republic of Korea. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080 Republic of Korea.
ORCID-Profile: Yun-Sang Lee
Zitieren
APA
Lee, Y. S. (2026). The 2026 Special Issue on Radiopharmaceuticals: from Molecular Design to Clinical Translation. Nuclear Medicine and Molecular Imaging, 60(3), 155-156. https://doi.org/10.1007/s13139-026-01019-2
Vancouver
Lee YS. The 2026 Special Issue on Radiopharmaceuticals: from Molecular Design to Clinical Translation. Nuclear Medicine and Molecular Imaging. 2026;60(3):155-156. doi:10.1007/s13139-026-01019-2
BibTeX
@article{Lee2026,
author = {Lee, Yun-Sang},
title = {The 2026 Special Issue on Radiopharmaceuticals: from Molecular Design to Clinical Translation},
journal = {Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {60},
number = {3},
pages = {155--156},
doi = {10.1007/s13139-026-01019-2}
}
EUVIMED